J&J | JNJ - Beneficio Operativo

Precio De Mercado
227.35
Cambio Diario
-0.44 -0.19%
Mensual
-6.24%
Anual
45.45%
Q2 Expectativa
222.63




Beneficio Operativo Cambio Fecha
AbbVie USD 4.73B 1.08B 2026-03
Abbott USD 1.85B 399M 2026-03
Amgen USD 3.96B 464M 2025-12
AstraZeneca USD 7.11B 4.14B 2026-03
Baxter International USD -214.2M 415.4M 2025-12
Bayer EUR 1.11B 1.65B 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Biogen USD 514.3M 128.8M 2026-03
Boston Scientific USD 1.05B 190M 2026-03
Bristol-Myers Squibb USD 4.2B 562M 2025-12
CONMED USD 36.62M 24.74M 2025-12
Cooper Companies USD 212.8M 72.4M 2025-12
Dexcom USD 323M 80.5M 2025-12
Edwards Lifesciences USD 514.7M 144.4M 2026-03
Eli Lilly USD 8.99B 599.9M 2025-12
Gilead Sciences USD 2.96B 551M 2025-12
GlaxoSmithKline GBP 2.29B 856M 2026-03
Globus Medical USD 181.31M 298.83M 2025-12
Insulet USD 146.3M 28.6M 2025-12
Integra LifeSciences USD 66M 54.24M 2025-12
Intuitive Surgical USD 859.7M 5.6M 2026-03
J&J USD 6.62B 1.03B 2026-03
Medtronic USD 1.74B 40M 2025-12
Merck USD 6.24B 318M 2025-12
Merit Medical Systems USD 54.2M 11.58M 2025-12
Novartis USD 4.24B 171M 2026-03
Pfizer USD 4.65B 3.99B 2025-12
Regeneron Pharmaceuticals USD 744.8M 153.8M 2026-03
Roche Holding CHF 9.56B 3.8B 2025-12
Sanofi EUR 1.94B 239M 2026-03
Stryker USD 1.97B 609M 2025-12
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teva Pharmaceutical Industries USD 758M 271M 2026-03
Vertex Pharmaceuticals USD 1.26B 24.5M 2025-12
Zimmer Biomet Holdings USD 395.1M 92.2M 2026-03
Zoetis USD 835M 101M 2025-12